Intellia Therapeutics (NTLA) Treasury Shares (2015 - 2026)

Intellia Therapeutics (NTLA) has 12 years of Treasury Shares data on file, last reported at $6.3 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $6.3 million, up 13.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 13.83% YoY), and the FY2025 annual result was $5.2 million, down 6.33% from the prior year.
• Treasury Shares rose to $6.3 million in Q1 2026 per NTLA's latest filing, from $5.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $6.3 million in Q1 2026 and troughed at $1.4 million in Q1 2022.
• A 5-year average of $4.3 million and a median of $5.2 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 334.88% in 2022, then retreated 6.33% in 2025.
• A 5-year view of Treasury Shares shows it stood at $1.9 million in 2022, then surged by 108.19% to $4.0 million in 2023, then surged by 37.26% to $5.5 million in 2024, then decreased by 6.33% to $5.2 million in 2025, then increased by 21.05% to $6.3 million in 2026.
• Business Quant data shows NTLA's Treasury Shares at $6.3 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.